Using Gadolinium Contrast Dye with Epidural Steroid Injections Linked to “Terrible” Side Effects: Study
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
AFFF Lawsuit Exposure to firefighting foam chemicals may result in an increased risk of cancer for firefighters, military and airport personnel.
FDA Reviewing New MRI Contrast Agent as Alternative to Gadolinium August 26, 2008 AboutLawsuits Add Your Comments The FDA has granted a Fast Track Designation to a new type of MRI contrast agent, ferumoxytol, which could be a safer alternative to gadolinium-based contrast agents for individuals with chronic kidney problems. Gadolinium MRI contrast agents, which allow the doctor to differentiate blood vessels from nearby tissue, have been linked to a potential risk of nephrogenic systemic fibrosis (NSF) for individuals with moderate to severe kidney problems. The devastating progressive condition, which is also sometimes referred to as nephrogenic fibrosing dermopathy (NFD), is associated with a hardening and thickening of the skin and connective tissue. The rigid and coarse skin that can form around the joints leads to severe restriction on movement, often requiring use of a wheelchair within weeks of the first symptoms. Learn More About Gadolinium MRI Lawsuits Following an MRI with contrast, Gadolinium Deposition Disease may result in painful and debilitating problems. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Gadolinium MRI Lawsuits Following an MRI with contrast, Gadolinium Deposition Disease may result in painful and debilitating problems. Learn More SEE IF YOU QUALIFY FOR COMPENSATION There is no cure or consistently successful treatment for NSF, and it often contributes to a premature death. The FDA added a “black box” warning to gadolinium based contrast agents last year, advising doctors to screen patients for impaired renal function before an Enhanced MRI. The FDA reserves the Fast Track Designation for products that are intended for treatment of serious or adverse conditions or have the potential for use in unmet medical needs. This designation helps to accelerate the process of development and review of these products by allowing more frequent interactions with the FDA and by various other means. The FDA’s decision to allow a quicker approval process for fermoxytol was mainly driven by the potential for this newer diagnostic agent to serve as a safe alternative for individuals with chronic kidney disease to obtain a Vascular Enhanced (VE) MRI for assessment of peripheral arterial disease. If approved, it could be a life-saving alternative to the gadolinium-based contrast agent for individuals with advanced kidney disease. Ferumoxytol is manufactured by AMAG Pharmaceuticals. The firm’s President and Chief Executive, Brian J.G. Pereira, said in a statement, “We plan to initiate a Phase II study of Ferumoxytol for VE-MRI for the detection of clinically significant arterial stenosis or occlusion in subjects with intermittent claudication (leg pain with walking) in the third quarter of 2008”. AMAG Pharmaceuticals anticipates FDA action on its new drug application (NDA) in the second half of October 2008. Tags: Ferumoxytol, Gadolinium, MRI, Nephrogenic Systemic Fibrosis Image Credit: | More Gadolinium Lawsuit Stories Using Gadolinium Contrast Dye with Epidural Steroid Injections Linked to “Terrible” Side Effects: Study November 15, 2022 Gadolinium-Based MRI Contrast Agents Linked To Hypersensitivity Reactions: Study February 23, 2022 Recent Strokes May Increase Gadolinium Brain Deposition Following MRI with Contrast: Study February 12, 2021 2 Comments mona January 4, 2010 I appreciate the information. I have had gadolinium a number of times. Where I have been going, they want to use gadolinium in me. I told them no a number of times. I have terrible pain in my joints, my only kidney bothers me, and I have other symptoms. My skin is not like orange peel but it always itches. When will”we” know if Ferumoxytol is “safe” to use in place of gadolinium? I need more MRI’s but are they as thorough “without contrast”? Can someone please answer my 2 questions? Thank you. charles August 8, 2019 I have questionable renal function and am not a candidate for gadolinium. At no time has Ferumoxytol been mentioned. I have suspected Acoustic Neuroma which very shortly has to be confirmed. Is Ferumoxytol approved and safe? If a response is coming I wwould appreciate if I received through my email. I have not reviewed my comments with a lawyer as I believe the two questions asked can be answered with no legal jeopardy. Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermEmailThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Four BioZorb Breast Tissue Marker Lawsuits Selected for Bellwether Trials (Posted: today) As new BioZorb lawsuits continue to be filed over complications with the recalled breast tissue markers, lawyers indicate they are on track for the first of four test cases to go before a jury in September 2025. MORE ABOUT: BIOZORB LAWSUITCourt Clears BioZorb Lawsuit Design Defect Claims Over Recalled Breast Tissue Marker (03/26/2025)Group of 7 BioZorb Injury Lawyers Appointed to Leadership Positions in Lawsuits Over Recalled Breast Tissue Marker (03/19/2025)Breast Cancer Survivors File Lawsuit Over Recalled BioZorb Tissue Marker (03/12/2025) Depo-Provera Meningioma Diagnosis Information Required To Qualify for Lawsuit: Order (Posted: yesterday) Women pursuing Depo-Provera meningioma lawsuits will have to provide documentary proof of their diagnosis and the versions of the birth control shot they received within 120 days of filing their case. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Lawsuit Timeline for Preparing Pilot Trial Cases Outlined by MDL Judge (03/24/2025)Women Can File Depo-Provera Brain Tumor Lawsuits Directly in MDL: Court Order (03/18/2025)75 Lawyers in Depo-Provera Lawsuits Seek MDL Leadership Roles (03/10/2025) Cartiva SCI Lawsuit Alleges Toe Implant Worsened Pain, Decreased Range of Motion (Posted: 2 days ago) An Indiana woman has filed a Cartiva SCI implant lawsuit, indicating that the toe implant failed due to a defective design, resulting in the need for revision surgery and recommendations to permanently fuse her big toe. MORE ABOUT: CARTIVA IMPLANT LAWSUITCartiva Implant Injury Lawsuit Set for Trial in February 2026 (03/07/2025)Lawsuit Indicates Cartiva Implant Fails in 2 Out of 3 Patients, But Continued To Be Sold in U.S. (02/13/2025)Cartiva Toe Implant Lawsuit Filed Over Worsened Pain, Reduced Range of Motion and Need for Surgical Removal (02/07/2025)
Using Gadolinium Contrast Dye with Epidural Steroid Injections Linked to “Terrible” Side Effects: Study November 15, 2022
Recent Strokes May Increase Gadolinium Brain Deposition Following MRI with Contrast: Study February 12, 2021
Four BioZorb Breast Tissue Marker Lawsuits Selected for Bellwether Trials (Posted: today) As new BioZorb lawsuits continue to be filed over complications with the recalled breast tissue markers, lawyers indicate they are on track for the first of four test cases to go before a jury in September 2025. MORE ABOUT: BIOZORB LAWSUITCourt Clears BioZorb Lawsuit Design Defect Claims Over Recalled Breast Tissue Marker (03/26/2025)Group of 7 BioZorb Injury Lawyers Appointed to Leadership Positions in Lawsuits Over Recalled Breast Tissue Marker (03/19/2025)Breast Cancer Survivors File Lawsuit Over Recalled BioZorb Tissue Marker (03/12/2025)
Depo-Provera Meningioma Diagnosis Information Required To Qualify for Lawsuit: Order (Posted: yesterday) Women pursuing Depo-Provera meningioma lawsuits will have to provide documentary proof of their diagnosis and the versions of the birth control shot they received within 120 days of filing their case. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Lawsuit Timeline for Preparing Pilot Trial Cases Outlined by MDL Judge (03/24/2025)Women Can File Depo-Provera Brain Tumor Lawsuits Directly in MDL: Court Order (03/18/2025)75 Lawyers in Depo-Provera Lawsuits Seek MDL Leadership Roles (03/10/2025)
Cartiva SCI Lawsuit Alleges Toe Implant Worsened Pain, Decreased Range of Motion (Posted: 2 days ago) An Indiana woman has filed a Cartiva SCI implant lawsuit, indicating that the toe implant failed due to a defective design, resulting in the need for revision surgery and recommendations to permanently fuse her big toe. MORE ABOUT: CARTIVA IMPLANT LAWSUITCartiva Implant Injury Lawsuit Set for Trial in February 2026 (03/07/2025)Lawsuit Indicates Cartiva Implant Fails in 2 Out of 3 Patients, But Continued To Be Sold in U.S. (02/13/2025)Cartiva Toe Implant Lawsuit Filed Over Worsened Pain, Reduced Range of Motion and Need for Surgical Removal (02/07/2025)